Adam Beharry, Yi Gong, James Kim, Killian S Hanlon, Josette Nammour, Kate Hieber, Florian Eichler, Ming Cheng, Anat Stemmer-Rachamimov, Konstantina Stankovic, Brad Welling, Carrie Ng, Casey A Maguire
Intrathecal delivery of AAV9 into the subarachnoid space has been shown to transduce spinal cord and brain and be less affected by pre-existing antibodies, which are lower in cerebral spinal fluid (CSF). Still, efficiency of transduction needs to be improved. Recently we identified a new capsid from a library selection in mice, called AAV-F, that allowed robust transduction of the spinal cord gray matter after lumbar injection. Here we test transduction of spinal cord by AAV-F (n=3) compared to AAV9 (n=2), using a reporter gene, in cynomolgus monkeys after lumbar intrathecal injection...
June 15, 2021: Human Gene Therapy